Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Camurati-Engelmann Syndrome × Paclitaxel × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 107 Breast Neoplasms 96 Ovarian Neoplasms 56 Triple Negative Breast Neoplasms 48 Squamous Cell Carcinoma of Head and Neck 38 Fallopian Tube Neoplasms 36 Lung Neoplasms 35 Endometrial Neoplasms 35 Neoplasms 26 Neoplasm Metastasis 26 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Stomach Neoplasms 23 Esophageal Neoplasms 21 Esophageal Squamous Cell Carcinoma 17 Uterine Cervical Neoplasms 14 Head and Neck Neoplasms 14 Colorectal Neoplasms 13 Carcinoma 13 Carcinoma, Ovarian Epithelial 12 Carcinoma, Squamous Cell 10 Small Cell Lung Carcinoma 9 Urinary Bladder Neoplasms 8 Adenocarcinoma Of Esophagus 8 Oropharyngeal Neoplasms 7 Melanoma 7 Carcinoma, Transitional Cell 7 Pancreatic Neoplasms 6 Mouth Neoplasms 6 Inflammatory Breast Neoplasms 6 Adenocarcinoma 6

Interventions

pembrolizumab 1 fludarabine 1 Radiotherapy, Intensity-Modulated 1 LY3300054 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡